Thyroid cancer is the most common endocrine cancer. The discovery of new biomarkers for
thyroid cancer has significantly improved the understanding of the molecular pathogenesis …

Angiogenesis is an important and interesting scientific subject in the area of malignant
tumours. Current research importance and interest are directed in connection to blood …

Background Patients with radioiodine-refractory differentiated thyroid cancer (DTC)
previously treated with vascular endothelial growth factor receptor (VEGFR)-targeted …

Thyroid cancer, as one of the most common endocrine cancers, has seen a surge in
incidence in recent years. This is most likely due to the lack of specificity and accuracy of its …

Angioinvasion remains the important prognostic feature in papillary thyroid cancer (PTC)
patients. Literature data indicates several markers that may be associated with oxidative …

Abstract On September 17, 2021, the FDA approved cabozantinib (Cabometyx; Exelixis,
Inc.) for the treatment of adult and pediatric patients 12 years of age and older with locally …

Thyroid cancer is the most common endocrine malignancy and several genetic events have
been described to promote the development of thyroid carcinogenesis. Besides the effects of …

Background The authors report results from the thyroid carcinoma cohort of the multicohort
phase 2 KEYNOTE‐158 study (NCT02628067), which evaluated pembrolizumab …

Simple Summary Thyroid-stimulating hormone (TSH) plays a role in the regulation of thyroid
hormones and is an important indicator for assessing thyroid function. Thyroid cancer (TC) is …

Thyroid cancer is a common endocrine carcinoma that occurs in the thyroid gland. Much
effort has been invested in improving its diagnosis, and thyroidectomy remains the primary …